KRAS and colorectal cancer: We did not find any relationship between KRAS-LCS6 genotype and overall survival when considering all colorectal cancer patients regardless of treatment and stage (Fig.2), although there was a moderately large amount of heterogeneity between studies (P = 0.003, I2 = 65.6%).